BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 3142676)

  • 21. High expression of adhesion molecules/activation markers with little interleukin-2, interferon gamma, and tumor necrosis factor beta gene activation in fresh tumor-infiltrating lymphocytes from lung adenocarcinoma.
    Roussel E; Gingras MC; Grimm EA; Roth JA
    Cancer Immunol Immunother; 1995 Jul; 41(1):1-9. PubMed ID: 7641214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphokine-activated killer (LAK) cell activity in tumor-infiltrating lymphocytes from non-small cell lung cancer.
    Pisani RJ; Krco CJ; Wold LE; McKean DJ
    Am J Clin Pathol; 1989 Oct; 92(4):435-46. PubMed ID: 2552792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural killer activity of lymphocytes infiltrating human lung cancers following preoperative systemic recombinant interleukin 2.
    Anderson TM; Ibayashi Y; Tokuda Y; Colquhoun S; Holmes C; Golub SH
    Arch Surg; 1987 Dec; 122(12):1446-50. PubMed ID: 3500691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of interleukin-12 on in vitro culture with interleukin-2 of regional lymph node lymphocytes from lung cancer patients.
    Hanagiri T; Takenoyama M; Yoshimatsu T; Hirashima C; Yoshino I; Nakanishi K; Nagashima A; Nomoto K; Yasumoto K
    Cancer Immunol Immunother; 1996 Oct; 43(2):87-93. PubMed ID: 8954142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional characterization of tumor-infiltrating lymphocytes, lymph-node lymphocytes and peripheral-blood lymphocytes from patients with breast cancer.
    Rubbert A; Manger B; Lang N; Kalden JR; Platzer E
    Int J Cancer; 1991 Aug; 49(1):25-31. PubMed ID: 1908441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural killer, lymphokine-activated killer and interferon-gamma producing activities of peripheral blood- and regional lymph node-mononuclear cells in 23 cases of colorectal cancer.
    Matsunaga H; Kuwahara Y; Kusugami K; Morise K; Shimokata K
    Gastroenterol Jpn; 1988 Oct; 23(5):527-33. PubMed ID: 3145895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct cytotoxicity against neuroblastoma cells of peripheral blood and tumor-infiltrating lymphocytes from patients with neuroblastoma.
    Kataoka Y; Matsumura T; Yamamoto S; Sugimoto T; Sawada T
    Cancer Lett; 1993 Sep; 73(1):11-21. PubMed ID: 8402593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Similarities between LAK cells derived from human thymocytes and peripheral blood lymphocytes: expression of the NKH-1 and CD3 antigens.
    Ramsdell FJ; Gray JD; Golub SH
    Cell Immunol; 1988 Jun; 114(1):209-21. PubMed ID: 2967111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of the frequency of regulatory T cells in regional lymph node lymphocytes as a prognostic factor for non-small-cell lung cancer.
    Hanagiri T; Shigematsu Y; Shinohara S; Takenaka M; Oka S; Chikaishi Y; Nagata Y; Iwata T; Uramoto H; So T; Tanaka F
    Lung Cancer; 2013 Sep; 81(3):475-479. PubMed ID: 23891508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Properties of recombinant interleukin 2-cultured tumor-infiltrating lymphocytes in human lung cancer.
    Yano T; Yasumoto K; Togami M; Ishida T; Kimura G; Sugimachi K; Nomoto K
    Int J Cancer; 1989 Apr; 43(4):619-23. PubMed ID: 2495250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term interleukin 2-dependent growth and cytotoxic activity of tumor-infiltrating lymphocytes from human squamous cell carcinomas of the head and neck.
    Heo DS; Whiteside TL; Johnson JT; Chen KN; Barnes EL; Herberman RB
    Cancer Res; 1987 Dec; 47(23):6353-62. PubMed ID: 3315186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor-draining lymph nodes of primary lung cancer patients: a potent source of tumor-specific killer cells and dendritic cells.
    Kimura H; Dobrenkov K; Iida T; Suzuki M; Ando S; Yamamoto N
    Anticancer Res; 2005; 25(1A):85-94. PubMed ID: 15816523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
    Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
    J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenotypic and functional analysis of tumor-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and peripheral blood lymphocytes in patients with advanced ovarian cancer.
    Santin AD; Hermonat PL; Ravaggi A; Bellone S; Roman JJ; Smith CV; Pecorelli S; Radominska-Pandya A; Cannon MJ; Parham GP
    Gynecol Obstet Invest; 2001; 51(4):254-61. PubMed ID: 11408737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The human lymphokine-activated killer cell system. V. Purified recombinant interleukin 2 activates cytotoxic lymphocytes which lyse both natural killer-resistant autologous and allogeneic tumors and trinitrophenyl-modified autologous peripheral blood lymphocytes.
    Grimm EA; Wilson DJ
    Cell Immunol; 1985 Sep; 94(2):568-78. PubMed ID: 3928175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and selection of human lymphokine activated killer cell effectors and novel recycling intermediates by unique light-scattering properties.
    Loudon WG; Abraham SR; Owen-Schaub LB; Hemingway LL; Hemstreet GP; DeBault LE
    Cancer Res; 1988 Apr; 48(8):2184-92. PubMed ID: 3258186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The absence of lymphoid suppressor cells in tumor-involved lymph nodes of patients with head and neck cancer.
    Letessier EM; Sacchi M; Johnson JT; Herberman RB; Whiteside TL
    Cell Immunol; 1990 Oct; 130(2):446-58. PubMed ID: 2145080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphokine-activated killer cell activity of peripheral blood, spleen, regional lymph node, and tumor infiltrating lymphocytes in gastric cancer patients.
    Karimine N; Nanbara S; Arinaga S; Asoh T; Ueo H; Akiyoshi T
    J Surg Oncol; 1994 Mar; 55(3):179-85. PubMed ID: 8176929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immune reactivities of lymphocytes from peripheral blood, regional lymph nodes and tumor-infiltrating lymphocytes in breast cancer].
    Hisamatsu K; Toge T; Yanagawa E; Hamada Y; Seto Y; Yamada H; Toi M; Hattori T
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2555-61. PubMed ID: 2943228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripheral blood and tumor infiltrating lymphocytes in non-small cell lung cancer: analysis at the population and clonal level.
    Viale M; Ferrini S; Serrano S; Serrano D; Ardizzoni A; Nicolin A
    Tumori; 1990 Oct; 76(5):488-94. PubMed ID: 2175060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.